IMG Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.5K Hold
33
﹤0.01% 367
2025
Q4
$5.5K Hold
33
﹤0.01% 400
2025
Q3
$4.7K Hold
33
﹤0.01% 358
2025
Q2
$4.11K Hold
33
﹤0.01% 369
2025
Q1
$4.16K Buy
33
+1
+3% +$136 ﹤0.01% 243
2024
Q4
$4.29K Buy
+32
New +$4.5K ﹤0.01% 210

Other funds holding IBB

IMG Wealth Management's IBB Position: Q1 2026 in Review

IMG Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 33 shares worth $5.5K. The position accounts for ﹤0.01% of the portfolio, ranked #367.

IMG Wealth Management first reported a position in IBB in Q4 2024 and has held it in 6 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • IMG Wealth Management held 33 shares of iShares Biotechnology ETF worth $5.5K as of Q1 2026.
  • IMG Wealth Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of IMG Wealth Management's portfolio in Q1 2026, its #367 holding.
  • IMG Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on IMG Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.